Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
39 Cards in this Set
- Front
- Back
- 3rd side (hint)
Catalyzes the activation of antithrombin III to decrease thrombin and Xa
Uses (2) site of action? |
Heparin
Uses: Immediate anticoagulation (PE, MI, stroke, DVT), Used during pregnancy (does not cross) site: Blood |
|
|
Interferes w/ factors II, VII, IX and X and protein C and S
Use site of action? |
Warfarin
use: Chronic coagulation [the EX-PaTriot went to WAR] EXtrinsic-PT pathway site: Liver |
|
|
drug class that aids in conversion of plasminogen to plasmin (which cleaves thrombin and fibrin clots)
name (4) |
Thrombolytics
Streptokinase, Urokinase, tPA (alteplase), Antistreplase |
|
|
what inhibits plasminogen to plasmin?
|
Aminocaproic acid
|
|
|
what glycoprotein in platelet binds to exposed collagen?
which bind together to aggregate? |
to collagen: GP-1a
together: GP-IIb/IIIa |
|
|
The only irreversible binder in the group to inhibit COX-1 and COX-2
|
Aspirin
|
|
|
drug inhibits platelet binding by irreversibly blocking ADP receptors, thereby inhibiting fibrinogen binding by preventing GP-IIb/IIIa expression
(2) uses AE? |
Clopidogrel
use: Acute Coronary syndrome, Coronary stenting AE: Neutropenia (tiCLOPidine) |
|
|
drug that binds directly to GP-IIb/IIIa on activated platelets, preventing aggregation
use? |
Abciximab
use: Angioplasty |
|
|
S-phase specific anti-cancer drugs
(5) |
Methotrexate,
5-FU, Cytarabine, 6-MP, Hydroxyurea |
|
|
S-phase antimetabolite that inhibits DHF reductase resulting in low dTMP
(2) AE? |
Methotrexate
AE: Myelosuppression, Macrovesicular fatty liver |
|
|
what reduces the myelosuppression toxicity in Methotrexate?
|
Leucovorin
|
|
|
S-phase pyrimidine analog that inhibits thymidylate synthase, resulting in low dTMP
(3) uses (2) AE |
5-Fluorouricil (5-FU)
uses: Colon CA, solid tumors, Basal cell CA AE: Myelosuppression, photosensitivity |
|
|
S-phase that blocks Purine synthesis and is activated by HGPRTase
(2) uses? what can increase toxicity? |
6-Mercaptopurine (6-MP)
use: Leukemias (not CLL) Lymphomas (not Hodgkin) inc Toxicity: Allopurinol (metabolized by Xanthine Oxidase) |
|
|
S-phase tha inhibits DNA polymerase to compete w/ dCTP
use? (3) AE |
Cytarabine (ARA-C)
use: AML AE: Leukopenia, Thrombocytopenia, Megaloblastic anemia |
|
|
Alkylating agent covalently x-link DNA at guanine N-7
use (3) AE |
Cyclophosphamide
use: Non-Hodgkins lymphomas, Breast CA, Ovarian CA AE: hemorrhagic CYSTITIS |
|
|
Alkylating agent class that crosses BBB
name drugs (2) AE |
Nitrosoureas
drugs: "-MUSTINE" Streptozocin AE: CNS toxicity (dizzy, ataxia) |
|
|
(2) anti-cancer drugs that act like Alkylating agents and form free radicals; they cause AE of Ototoxicity and Nephrotoxicity
use (4) |
Cisplatin, Carboplatin
use (BOLT): Bladder CA, Ovarian CA, Lung CA, Testicular CA, [BOLT ON the PLAnTation] |
|
|
Alkalaying agent of DNA used as DOC for CML
(2) AE |
Busulfan
AE: Pulmonary fibrosis, hyperpigmentation |
|
|
(2) anti-cancers that generates free radicals and noncovalently intercalate in DNA (breaking strands); AE include cardiotoxicity
(2) uses another AE |
Doxorubicin (Adriamycin),
Danorubicin use: Hodgkins (A in ABVD combo) solid tumors AE: Alopecia |
|
|
another name for:
Doxorubicin |
Adriamycin
|
|
|
what anti-cancer drug that intercalates in DNA, is used for childhood tumors?
|
ACTinomycin-D
[children ACT out] |
|
|
drug that induces formation of free radicals to cause breaks in DNA; AE is pulmonary fibrosis
(2) uses |
Bleomycin
use: Testicular CA, Hodgkins (B in ABVD combo) |
|
|
G2-specific agent that inhibits Topoisomerase-II
(3) uses |
EToPoSide (VP-16)
uses: T: Testicular CA, P: Prostate CA, S: Small cell CA of lung |
|
|
MC glucocorticoid in cancer therapy
(2) uses aside from usual corticoid AE (cushings, osteoporosis) what other AE? |
Prednisone
use: Hodgkins (P in MOPP combo) CLL AE: cataracts |
|
|
monoclonal Ab against HER-2 (erb-B2)--Breast CA
AE |
Trastuzumab (HERceptin)
AE: Cardiotoxicity |
|
|
monoclonal Ab against the Philadelphia chromosome brc-abl tyrosine kinase
|
Gleecec (Imatinib)
|
|
|
M-phase specific alkaloids that bind to tubulin and block polymerization of microtubules so that spindle fibers cannot form
use (3) AE (2) |
Vincristine ("Oncovin"); Vinblastine
use: Hodgkins (O in MOPP combo), Wilm's Tumor, Choriocarcinoma AE: Vincristine - Neurotoxicity Vinblastine - BLASTs bone marrow |
|
|
M-phase specific that bind to tubulin and hyperstabilize polymerized microtubules so that spindle fibers cannot breakdown (anaphase cant occur)
use (2) AE (2) |
Taxols (Paclitaxel)
use: Ovarian CA Breast CA AE: myelosuppression, Hypersensitivity |
|
|
what are the drugs in the ABVD Hodgkins combo?
|
Adriamycin (doxorubicin),
Bleomycin, Vinblastine, Dacarabazine |
|
|
what are the drugs in the MOPP Hodgkins combo?
|
Mechlorethamine
Oncovoin (Vincristine) Prednisone Procarbazine |
|
|
DOC for CLL
|
Prednisone
|
|
|
DOC in CML
(2) |
Gleevac,
Busulfan |
|
|
DOC in AML
|
Cytarabine
|
|
|
anti-cancer drug that causes Pancreatitis
|
Asparaginase
|
|
|
anti-cancer drug that causes oral and GI ulcers
|
5-FU
|
|
|
which ant-cancer drugs are clasified as Alkylating agents?
(4)* |
"at NITe the CYCLOne picked-up the BUS and CAR"
NITrosureas, CYCLOphosphamide, BUSulfan, CARboplatin, cisplatin |
at NITe the CYCLOne picked-up the BUS and CAR
|
|
what anti-cancer drug works in the G-0 phase?
|
Busulfan
|
|
|
which anti-cancer drugs generate free radicals?
(3)* |
BAD radicals:
Bleomycin, Actinomycin-D, Doxorubicin, Daunorubicin |
BAD radicals
|
|
(2) drugs that work in the G-2 phase
|
Bleomycin,
Etoposide (VP-16) |
|